Mirum Pharmaceuticals, Inc. MIRM
Set alert
87.70 USD +1.96 +2.29%
As of Nov 3, 12:40 PM ET
85.89 Day range 88.54
63.23 52-week range 130.00
- YTD
- +11.03%
- 1 year
- +23.78%
- Open
- 85.89
- Prev close
- 85.74
- Mkt cap
- 5.70B
- Vol
- 186.54K
- Avg vol
- 723.78K
- EPS
- -14.10
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 85.89
- High
- 88.54
- Forward P/E
- -121.62
- Beta
- 0.74
- Short ratio
- 7.16
- Inst. own
- 113.63%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 89.93
- 200-d avg
- 98.57
- 1y target
- 153.43
MAX chart
Events in this range
- Aug 6, 2025Earnings: -0.12; estimate -0.31; surprise 61.29%
- Nov 4, 2025Earnings: 0.05; estimate -0.1; surprise 150%
- Feb 25, 2026Earnings: -0.11; estimate 0.02; surprise -650%
- May 6, 2026Earnings: -13.43; estimate -0.4; surprise -3257.5%
- Aug 5, 2026Earnings: -1.06; estimate -0.74254; surprise -42.75%
- Oct 12, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Oct 12, 2026Rating: Citigroup · Buy → Buy
- Oct 13, 2026Rating: Morgan Stanley · Overweight → Overweight
- Oct 13, 2026Rating: Evercore ISI Group · Outperform → Outperform
- Oct 15, 2026Rating: Stifel · Buy → Buy
- Oct 21, 2026Rating: TD Cowen · Buy → Buy
- Nov 3, 2026Earnings: —; estimate -0.48682; surprise —%
Signals (146)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 27, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 27, 2026 | 3 months ago |
| RSI: Overbought | Jun 29, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | Apr 27, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 9, 2026 | 7 months ago |
| SMA: Bearish | Feb 23, 2026 | 8 months ago |
| MACD: Buy Signal | Jan 5, 2026 | 10 months ago |
| RSI: Overbought | Jan 5, 2026 | 10 months ago |
| SMA: Bullish | Dec 15, 2025 | 10 months ago |
| SMA: Bearish | Dec 1, 2025 | 11 months ago |
| SMA: Bullish | Nov 24, 2025 | 11 months ago |
| MACD: Sell Signal | Oct 27, 2025 | 1 year ago |
| SMA: Bearish | Oct 20, 2025 | 1 year ago |
| RSI: Overbought | Aug 4, 2025 | 1 year ago |
Newest 20 of 146.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 153.43 +74.9% upside
Now 87.70
- Target (low)
- 118.00
- Target (mean)
- 153.43
- Target (high)
- 200.00
Ratings (0m) 14 14 buy · 0 hold · 0 sell
- Strong buy4
- Buy10
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 14
- 1 month ago 14
- 2 months ago 14
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.415 | -0.53 – -0.30 | 0.05 | -930.0% | 178.04M | +33.9% | 2 |
| Next quarter | -0.44 | -0.44 – -0.44 | -0.12 | -266.7% | 183.22M | +23.0% | 1 |
| Current year | -15.23 | -15.23 – -15.23 | -0.47 | -3140.4% | 698.11M | +33.9% | 1 |
| Next year | -0.705 | -1.24 – -0.17 | -15.23 | +95.4% | 819.57M | +17.4% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 21, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 15, 2026 | Stifel | Maintained | Buy | Buy |
| Oct 13, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Oct 13, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 12, 2026 | Citigroup | Maintained | Buy | Buy |
| Oct 12, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 8, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Sep 29, 2026 | Citigroup | Maintained | Buy | Buy |
| Sep 29, 2026 | Baird | Maintained | Outperform | Outperform |
| Sep 28, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 27, 2026 | Citizens | Reiterated | Market Outperform | Market Outperform |
| Aug 6, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 6, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 6, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Aug 6, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 7, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 2, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jun 15, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Jun 11, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jun 2, 2026 | Citigroup | Initiated | — | Buy |
| May 19, 2026 | Wolfe Research | Initiated | — | Outperform |
| May 7, 2026 | TD Cowen | Maintained | Buy | Buy |
| May 7, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| May 7, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| May 7, 2026 | Baird | Maintained | Outperform | Outperform |
| May 5, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| May 4, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 29, 2026 | Stifel | Maintained | Buy | Buy |
| Apr 28, 2026 | Baird | Maintained | Outperform | Outperform |
| Apr 27, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
